Aridis Pharmaceuticals, Inc.

VANGUARD GROUP INC ARDS

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

136,197

Value ($000)

30

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	30	0.0%	136,197	6/30/2023
2023 Q1	7/14/2023	165	0.0%	525,156	3/31/2023
2022 Q4	2/10/2023	619	0.0%	524,453	12/31/2022
2022 Q3	11/14/2022	488	0.0%	524,122	9/30/2022
2022 Q2	8/12/2022	577	0.0%	524,122	6/30/2022
2022 Q1	5/13/2022	922	0.0%	524,122	3/31/2022
2021 Q4	2/14/2022	1,182	0.0%	507,337	12/31/2021
2021 Q3	11/12/2021	624	0.0%	169,537	9/30/2021
2021 Q2	8/13/2021	1,184	0.0%	159,946	6/30/2021
2021 Q1	5/14/2021	883	0.0%	149,658	3/31/2021
2020 Q4	2/12/2021	894	0.0%	147,424	12/31/2020
2020 Q3	11/16/2020	1,044	0.0%	147,424	9/30/2020
2020 Q2	8/14/2020	493	0.0%	74,302	6/30/2020
2020 Q1	5/15/2020	429	0.0%	74,302	3/31/2020
2019 Q4	2/14/2020	331	0.0%	74,302	12/31/2019